Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial.

Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial.

<h4>Background</h4>Patients with unprovoked (i.e., without the presence of apparent transient risk factors such as recent surgery) venous thromboembolism (VTE) are at risk of recurrence if anticoagulants are stopped after 3-6 months, yet their risk remains heterogeneous. Thus, prolonging...

Full description

Bibliographic Details
Main Authors: Geert-Jan Geersing, Janneke M T Hendriksen, Nicolaas P A Zuithoff, Kit C Roes, Ruud Oudega, Toshihiko Takada, Roger E G Schutgens, Karel G M Moons
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-06-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1003142

Internet

https://doi.org/10.1371/journal.pmed.1003142

Similar Items